Browsing by Subject "G01N 33/84"
Now showing items 1-5 of 5
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2015-09-15)The disclosure provides rifamycin and rifamycin derivative compositions, including rifabutin and rifabutin derivative compositions able to cause drug-sensitization in a cancer cell or inhibition of a cancer cell. The ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2018-01-16)The disclosure provides rifamycin and rifamycin derivative compositions, including rifabutin and rifabutin derivative compositions able to cause drug-sensitization in a cancer cell or inhibition of a cancer cell. The ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2017-01-10)The disclosure provides rifamycin and rifamycin derivative compositions, including rifabutin and rifabutin derivative compositions able to cause drug-sensitization in a cancer cell or inhibition of a cancer cell. The ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2014-08-26)The present disclosure relates to detecting receptor-ligand binding by measuring local pH modulation using a pH-sensitive fluorophore.
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2016-03-15)Methods and systems for detecting binding between first and second molecules using a pH-sensitive fluorophore. A change in fluorescence emission intensity of the fluorophore is indicative of binding.